Jordi Vila

45PUBLICATIONS
102CO-AUTHORS
Environmental epidemiologyMicrobial taxonomyMedical infection agents (incl. prions)Biomolecular modelling and designMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Oct 15, 2025
Molecular epidemiological characterization of enterotoxigenic and enteroaggregative Escherichia coli causing traveller's diarrhoea and their association with persistence of symptoms.

Pol Oliveras, Elisa Riera, Jimmy Lucas

|Sep 27, 2025
Trends in Antituberculosis Drug Resistance and Associated Factors: A 31-Year Observational Study at a Tertiary Hospital in Barcelona.

Mateu Espasa, Belén Pagán, Mariana Fernández-Pittol

|Aug 28, 2025
In Vitro and In Vivo Characterization of Novel Cathelicidin-Based Peptides with Antimicrobial Activity Against Pseudomonas aeruginosa.

Javier Moreno-Morales, Núria Martín-Vilardell, Salvador Guardiola

|Feb 26, 2025
Correction: Roson-Calero et al. Cyclic Peptide MV6, an Aminoglycoside Efficacy Enhancer Against Acinetobacter baumannii. Antibiotics 2024, 13, 1147.

Natalia Roson-Calero, Jimmy Lucas, María A Gomis-Font

|Jan 28, 2025
Novel PiuC, PirA, and PiuA mutations leading to in vivo cefiderocol resistance progression in IMP-16- and KPC-2-producing Pseudomonas aeruginosa from a leukemic patient.

Joaquim Viñes, Sabina Herrera, Andrea Vergara

|Jan 08, 2025
Cyclic Peptide MV6, an Aminoglycoside Efficacy Enhancer Against Acinetobacter baumannii.

Natalia Roson-Calero, Jimmy Lucas, María A Gomis-Font

Pageof 8

Frequent Collaborators

7 joint publications

Ignasi Roca

7 joint publications

Andrea Vergara

6 joint publications

Clara Ballesté-Delpierre

4 joint publications

Natalia Roson-Calero